Martin Koch
Direttore operativo presso Inotrem SA
Provenienza dei contatti di primo grado di Martin Koch
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
INSEAD
115
| College/University | Other Consumer Services | 115 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France.
11
| Holding Company | Biotechnology | 11 |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK.
4
| Subsidiary | Medical Distributors | 4 |
Institut National Agronomique Paris-Grignon
3
| College/University | Other Consumer Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Martin Koch tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of Bocconi | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Sciences Po | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Director/Board Member Graduate Degree | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Founder Director/Board Member | |
| École supérieure d'électricité | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Biotechnology | Chairman President | |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Director/Board Member Consultant / Advisor | |
UniCredit Services SCpA
 UniCredit Services SCpA Miscellaneous Commercial ServicesCommercial Services UniCredit Services SCpAprovides services in the Information and Communication Technology (ICT); back office and middle office; real estate; and security and procurement sectors. It operates through the following business lines: Commercial Banking Mature Markets; Commercial Banking Central and Eastern Europe (CEE); Transactional Products; Markets and Finance and Accounting; and Global Enterprise Services. The Commercial Banking Mature Markets line focuses on the core banking and credit and securities sectors. The Commercial Banking Central and Eastern Europe line specializes in ICT platforms to the CEE countries. The Transactional Products line ensures the global supply of end-to-end services regarding payments, cards, and other transactions. The Markets and Finance and Accounting line deals with the market utilities and trading and treasury production structures. The Global Enterprise Services line supplies end-to-end services related to competence line planning, finance and administration, human resources, legal and compliance, and audit. The company was founded on January 1, 2012 and is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Chief Operating Officer Director/Board Member | |
UniCredit Bank Austria AG
 UniCredit Bank Austria AG Major BanksFinance UniCredit Bank Austria AG provides banking and financial services to private and corporate clients. Its products and services include current accounts and credit cards, payments processing, savings and investments, foreign exchange hedging, loans and home financing, real estate financing, pension and insurance, cross border account opening and cash management. The company was founded in 1855 and is headquartered in Vienna, Austria. | Major Banks | Director/Board Member Director/Board Member | |
| YAPI VE KREDI BANKASI | Major Banks | Director/Board Member Director/Board Member | |
Koç Finansal Hizmetler AS
 Koç Finansal Hizmetler AS Financial ConglomeratesFinance Koç Finansal Hizmetler AS engages in the provision of financial services. Its services include financial leasing, factoring, investment banking, portfolio management, and consulting. The company was founded by Semahat Sevim Arsel, Rahmi Mustafa Koç, Daime Sevgi Gönül, and Suna Kiraç on March 16, 2001 and is headquartered in Istanbul, Turkey. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
| UNICREDIT S.P.A. | Major Banks | Chief Executive Officer Corporate Officer/Principal | |
| FINECOBANK S.P.A. | Major Banks | Director/Board Member Director/Board Member | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Bristol | College/University | Undergraduate Degree Undergraduate Degree | |
Institut Gustave Roussy EURL
 Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Oslo | College/University | Graduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Graduate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NOKIA OYJ | Telecommunications Equipment | Director/Board Member Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc. (United Kingdom)
 McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Advent International Ltd
 Advent International Ltd Investment ManagersFinance Advent International Plc provides investment services. It serves the business & financial, healthcare, industrial, retail, consumer & leisure, technology, media and telecoms sectors. The company was founded in 1989 and is located in London, UK | Investment Managers | Consultant / Advisor Private Equity Investor | |
| AIR LIQUIDE | Chemicals: Specialty | Sales & Marketing Director/Board Member | |
| MOLTIPLY GROUP S.P.A. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Politecnico di Torino | College/University | Undergraduate Degree Undergraduate Degree | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NIOX GROUP PLC | Medical/Nursing Services | Founder Director/Board Member | |
| STOREBRAND ASA | Savings Banks | Director/Board Member Director/Board Member | |
| BANG & OLUFSEN A/S | Electronics/Appliances | Director/Board Member Chief Executive Officer | |
| University of Geneva | College/University | Undergraduate Degree Undergraduate Degree | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
| University of Bern | College/University | Undergraduate Degree Graduate Degree | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
Oakfield Capital Partners LLP
 Oakfield Capital Partners LLP Investment ManagersFinance Oakfield Capital Partners LLP (Oakfield Capital Partners) is a private equity firm founded in 2008 by Roy Merritt and Michael Patton. The firm is headquartered in Richmond, United Kingdom. | Investment Managers | Founder Private Equity Investor | |
Telenor Danmark
 Telenor Danmark Wireless TelecommunicationsCommunications Telenor Danmark provides mobile telephone services and is ultimately controlled by the Government of Norway. The company is based in Copenhagen, Denmark. | Wireless Telecommunications | Chief Executive Officer Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Telenor A/S
 Telenor A/S Wireless TelecommunicationsCommunications Telenor A/S provides telecommunications services. The firm provides global system for Mobile communication and third generation mobile solutions for residential and business customers. It also offers broadband solutions and network-based products such as security and Virtual Private Network products. The company was founded in 1995 and is headquartered in Copenhagen, Denmark. | Wireless Telecommunications | Chief Executive Officer Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 11 |
| Francia | 10 |
| Svizzera | 7 |
| Stati Uniti | 7 |
| Italia | 7 |
Settori
| Consumer Services | 15 |
| Health Technology | 14 |
| Finance | 12 |
| Commercial Services | 6 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 579 |
| Chairman | 221 |
| Corporate Officer/Principal | 214 |
| Chief Executive Officer | 121 |
| Masters Business Admin | 82 |
Contatti più connessi
- Borsa valori
- Insiders
- Martin Koch
- Connessioni Società
